Navigation Links
Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
Date:8/16/2010

IRVINE, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has entered into a development agreement and exclusive license with Evasc Medical Systems Corp., for its balloon expandable stent technology. Evasc is a medical device development company located in Vancouver, B.C. The patented stent is made from cobalt chromium and is pre-mounted on an angioplasty balloon catheter for ease-of-use.

Endologix plans to cover the balloon expandable stent with its proprietary ePTFE graft material and utilize it in conjunction with the Company's fenestrated stent graft device, which is currently in pre-clinical development. The fenestrated stent graft will be a new aortic extension designed to be used with Endologix's Powerlink® main body bifurcated stent grafts. It is designed to provide an off-the-shelf, endovascular treatment option for short neck and juxtarenal abdominal aortic aneurysms (AAA), which require the graft to extend above the renal arteries in order to achieve proper fixation and sealing. The balloon expandable stent graft will be used to branch the fenestrated stent graft into the renal arteries, allowing normal blood flow to the kidneys.

John McDermott, President and Chief Executive Officer of Endologix, said, "This patented balloon expandable stent technology is an important addition to our product portfolio. It will be integrated into our fenestrated stent graft device, which will expand the endovascular AAA market to include short aortic necks and aneurysms that extend up above the renal arteries. Approximately 15% of diagnosed AAA patients have these conditions and the vast majority require open surgical repair due to the lack of fenestrated stent grafts in the market. The balloon expandable stent technology will also be developed into stand alo
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
7. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
8. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
9. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... and SYDNEY , May 16, ... - ASX: HIN), a leading innovator of less invasive, miniaturized ... heart failure, today announced that CEO Doug Godshall ... Global Healthcare Conference at 11:00 a.m. EDT on Monday, May ... at the Sheraton New York Hotel. A live ...
(Date:5/16/2013)... May 16, 2013 OrthoView PSL ... U.S. to access the widely-used OrthoView digital templating software ... Internet connection to get started. OrthoView, the ... over 10 years, is dedicated to enabling orthopaedic surgeons ... x-ray images, when printed film is unavailable. Over 5,000 ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... Study Confirms Role of AMBIEN CR in Effectively Managing Insomnia ... Improve Quantity and Quality of Work Performance, ... new study that showed patients with chronic,insomnia who were treated ... CIV experienced significant improvements in two,key parameters of work performance ...
... a division of Wyeth (NYSE: WYE ), ... (FDA) has accepted for filing the,Company,s supplemental New ... for the treatment of patients with,community-acquired pneumonia (CAP). ... application. The FDA may approve or disapprove the ...
Cached Medicine Technology:New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 3New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 4FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 2FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 3FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 4FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 5FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 6
(Date:5/19/2013)... Farming methods have changed many times since man ... ago. Most recently, the Green Revolution has transformed farming ... seeds and by applying chemical fertilizers and pesticides. But ... due to the adverse environmental and health effects of ... interest in organic, sustainable farming practices and techniques. Enter ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier ... the launch it's all new vacation packages for the ... 5/19/2013. Consumers traveling to Las Vegas will be pleased ... VegasHotelEscapes.com's website. Travelers will be pleased to know that ... , Vegas Hotel Escapes specializes in helping consumers ...
(Date:5/19/2013)... May 19, 2013 Exciting new Skin ... is reintroducing a great practice known through the ages ... known as dry body brushing, has so many benefits ... of Sublime Beauty®. "We love that circulation and lymphatic ... largest organ, the skin, is supported through Skin Brushing." ...
(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases de ... Argentina by the Sivananda Yoga Vedanta Center. The ... (Barrio Norte). Classes are 90 minutes and are offered ... in a calm environment, allowing visitors to enjoy the ... food, among others. , The Yoga classes follow the ...
(Date:5/19/2013)... Minor fender benders and serious car accidents are ... the accident to respond appropriately to the situation. ... data from 2010, accidents, including car accidents, are the ... in 2005, automobile accident-related deaths cost over ... million drivers and passengers receive treatment in an emergency ...
Breaking Medicine News(10 mins):Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2
... HealthDay Reporter , MONDAY, Nov. 7 (HealthDay News) - More ... drugs, with 32 percent saying they drink, 19 percent saying they ... study shows. , , An even closer look at the data ... to use drugs or alcohol, with almost 48 percent admitting they ...
... by 2007 annual sales of the cards were at 85,000. America ... in the U.S. over the age of 80 is expected to ... how well they live. The new book, Aging Our Way ... of 30 eldersranging in age from 85 to 102living at home ...
... the Johns Hopkins Center for Injury Research and Policy ... a strategic, comprehensive and coordinated approach to fire prevention. ... the state,s fire service, highlights the diversity of prevention ... dedication, and a sense of community are keys to ...
... (November XX, 2011) The Lymphoma Division of the John ... participation from the Facebook groups "Hope for Lymphoma" and "Our ... on Saturday, November 12 from 8:30am 3:45pm. The ... Mantle Cell Lymphoma (MCL) patients and their caregivers coping with ...
... A grant in excess of $3.5 million has been awarded ... to facilitate the production of new and investigational drugs for ... Central Texas cancer research program receiving the award from the ... to fund innovation and commercialization of cancer research in the ...
... published online Nov. 6 in Nature Medicine , investigators ... the development of osteoarthritis is in great part driven by ... view attributing the condition to a lifetime of wear and ... William Robinson, MD, PhD, the study,s senior author, of the ...
Cached Medicine News:Health News:More Than a Third of Teens Turning to Alcohol, Drugs: Study 2Health News:More Than a Third of Teens Turning to Alcohol, Drugs: Study 3Health News:What can we learn from America's fastest growing and least understood age group? 2Health News:Delaware Fire Service offers important lessons for fire prevention programs nationwide 2Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 2Health News:John Theurer Cancer Center to host inaugural Mantle Cell Lymphoma Symposium 3Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 2Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 3Health News:Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: